Psychiatrist-CNS
Psychiatrist.com is the online destination for three premier leaders in the psychiatry and CNS publishing space: the 82-year-old The Journal of Clinical Psychiatry, the digital-only The Primary Care Companion for CNS Disorders, and the ACCME-accredited CME Institute. Our mission is to provide lifelong learning for clinicians and researchers by offering evidence-based, peer-reviewed, scientific information about the diagnosis and treatment of behavioral health and neuropsychiatric disorders and diseases.
It Takes Guts to Be Mentally Ill. Part 2: The Relationship Between the Gut Microbiota and Psychosis
It Takes Guts to Be Mentally Ill. Part 1: A Brief Overview of the Human Gut Microbiota
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 2
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
The Near-Term Future of Muscarinic Agonists and Modulators for Schizophrenia: M1 and/or M4
Update on Current & Emerging Treatments for Negative Symptoms in Schizophrenia
Hypo- and Hyperactivity Symptoms Related to Norepinephrine Disturbances
The Role of Norepinephrine as a Common Treatment Target
What is the Role of the Muscarinic Receptor System in Schizophrenia?
Algorithms for TRD Treatment Success: Lessons from the Veterans Health Administration
Neurosteroids and Postpartum Depression
Interventional Neuropsychiatry
Overview of Norepinephrine Pathways and Modulation
The Role of Digital Phenotyping in Negative Symptoms Treatment Studies
Anticholinergic Burden in Schizophrenia
Prevalence and Determinants of Everyday Disability in Schizophrenia
Advanced Treatments, Limited Reach: Access in Interventional Psychiatry
PsychCase360: Balancing Psychiatric Stability and Cardiometabolic Health in Bipolar I Disorder
What are the Efficacy and Safety of Muscarinic Receptor Modulators in Patients With Schizophrenia?
What is the Place of Muscarinic Receptor Modulators in Clinical Care of Patients with Schizophrenia
The Case for Surgical Interventions in Treatment-Resistant Depression
Optimizing Recovery: Comprehensive Care Pathways for Depression
The Protective Effect of Clozapine on Suicide
5 Minute Pearls: Psychiatric Care Considerations for Sexually and Gender Diverse Populations
Impact of Tardive Dyskinesia on Patient Lives
Predictors for Initiation of Atypical LAIs in Individuals With Early-Phase Schizophrenia
Zuranolone in Major Depressive Disorder
5 Minute Pearls: Ketamine in Treatment Resistant Depression